Seeking Alpha

Corcept Therapeutics (CORT) intends to sell 11M shares to raise funds for R&D and other...

Corcept Therapeutics (CORT) intends to sell 11M shares to raise funds for R&D and other purposes. Corcept develops drugs for severe psychiatric and metabolic disorders, including Cushing's syndrome and psychotic depression. Shares -5.35% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)